Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis

Advances in Clinical and Experimental Medicine - Poland
doi 10.17219/acem/114762
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wroclaw Medical University

Related search

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Biomarkers and Disease Activity in Multiple Sclerosis : A Cohort Study on Patients With Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis

Linköping University Medical Dissertations
2019English

Stressful Events Increase Exacerbations in Relapsing-Remitting Multiple Sclerosis

BMJ
2003English

Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection

Archives of Neurology
2004English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Metabolites Predict Lesion Formation and Severity in Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis
Neurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy